| Primary |
| Atrial Fibrillation |
36.2% |
| Cardiac Disorder |
23.4% |
| Heart Rate Irregular |
8.5% |
| Cardiac Failure |
4.3% |
| Cardiac Failure Congestive |
4.3% |
| Cardiomyopathy |
4.3% |
| Arrhythmia |
2.1% |
| Bradycardia |
2.1% |
| Cardiac Valve Disease |
2.1% |
| Heart Rate Decreased |
2.1% |
| Hypertension |
2.1% |
| Multiple Sclerosis |
2.1% |
| Palpitations |
2.1% |
| Post Procedural Complication |
2.1% |
| Product Used For Unknown Indication |
2.1% |
|
| Pharmaceutical Product Complaint |
29.6% |
| Vomiting |
16.9% |
| Therapeutic Agent Toxicity |
7.0% |
| Visual Disturbance |
5.6% |
| Bradycardia |
4.2% |
| Nausea |
4.2% |
| Weight Decreased |
4.2% |
| Death |
2.8% |
| Fall |
2.8% |
| Heart Rate Increased |
2.8% |
| Sudden Death |
2.8% |
| Swelling |
2.8% |
| Unevaluable Event |
2.8% |
| Vision Blurred |
2.8% |
| Adverse Drug Reaction |
1.4% |
| Cardiac Disorder |
1.4% |
| Cardiac Failure Congestive |
1.4% |
| Cerebrovascular Accident |
1.4% |
| Diarrhoea |
1.4% |
| Dizziness |
1.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.6% |
| Pain |
14.8% |
| Cardiac Failure Congestive |
7.4% |
| Blood Cholesterol |
5.6% |
| Cardiac Disorder |
5.6% |
| Cardiac Failure |
5.6% |
| Bipolar Disorder |
3.7% |
| Convulsion |
3.7% |
| Coronary Artery Disease |
3.7% |
| Diabetes Mellitus |
3.7% |
| Fluid Retention |
3.7% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Transposition Of The Great Vessels |
3.7% |
| Bone Pain |
1.9% |
| Complex Regional Pain Syndrome |
1.9% |
| Squamous Cell Carcinoma |
1.9% |
|
| Blood Alkaline Phosphatase Increased |
11.5% |
| Pharmaceutical Product Complaint |
11.5% |
| Vomiting |
11.5% |
| Musculoskeletal Pain |
7.7% |
| Thrombocytopenia |
7.7% |
| Alopecia |
3.8% |
| Blood Pressure Increased |
3.8% |
| Cardiac Failure Congestive |
3.8% |
| Death |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Drug Intolerance |
3.8% |
| Fatigue |
3.8% |
| Hypertension |
3.8% |
| Sleep Disorder |
3.8% |
| Stomach Discomfort |
3.8% |
| Therapeutic Agent Toxicity |
3.8% |
| Tooth Fracture |
3.8% |
| Urinary Tract Infection |
3.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.1% |
| Product Used For Unknown Indication |
23.4% |
| Hypertension |
5.6% |
| Cardiac Disorder |
5.3% |
| Atrial Fibrillation |
4.8% |
| Pain |
4.1% |
| Colorectal Cancer Metastatic |
2.6% |
| Pulmonary Hypertension |
2.5% |
| Diabetes Mellitus |
2.4% |
| Osteoporosis |
2.3% |
| Arthritis |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Smoking Cessation Therapy |
1.9% |
| Pulmonary Arterial Hypertension |
1.8% |
| Cardiac Failure Congestive |
1.7% |
| Depression |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Blood Cholesterol Increased |
1.2% |
| Colorectal Cancer |
1.2% |
| Type 2 Diabetes Mellitus |
1.1% |
|
| Weight Decreased |
14.5% |
| Vomiting |
9.7% |
| Sepsis |
6.8% |
| Drug Ineffective |
6.1% |
| Weight Increased |
6.1% |
| Myocardial Infarction |
5.5% |
| Wheezing |
4.8% |
| Nausea |
4.5% |
| Syncope |
4.5% |
| Pharmaceutical Product Complaint |
4.2% |
| Thrombosis |
4.2% |
| Pain In Extremity |
3.9% |
| Pneumonia |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Urinary Tract Infection |
3.5% |
| Somnolence |
3.2% |
| Vasculitis |
3.2% |
| Visual Acuity Reduced |
2.9% |
| Dyspnoea |
2.6% |
| Oedema Peripheral |
2.6% |
|
